Akebia Therapeutics
AKBA
#9606
Rank
โ‚น9.91 B
Marketcap
โ‚น35.72
Share price
-8.71%
Change (1 day)
-74.27%
Change (1 year)

Akebia Therapeutics (AKBA) - Total debt

Total debt on the balance sheet as of June 2026 : โ‚น5.09 Billion

According to Akebia Therapeutics's latest financial reports the company's total debt is โ‚น5.09 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Akebia Therapeutics - Total debt on balance sheet (from 2013 to 2026)

Total debt by year

Year Total debt Change
2025-12-31โ‚น4.64 B13.78%
2024-12-31โ‚น4.08 B2.02%
2023-12-31โ‚น4.00 B-51.48%
2022-12-31โ‚น8.25 B-18.46%
2021-12-31โ‚น10.12 B9.64%
2020-12-31โ‚น9.23 B19.56%
2019-12-31โ‚น7.72 B636.49%
2018-12-31โ‚น1.04 B
2013-12-31โ‚น0.73 M
2012-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
โ‚น4.137 T 81,129.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น4.476 T 87,785.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น5.310 T 104,147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚น7.27 B 42.91%๐Ÿ‡บ๐Ÿ‡ธ USA